OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$6.94+0.30 (+4.52%)
Close on Nov 17, 2026Market cap $130.72MP/E 28.9Yield –
OptimizeRx pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
OptimizeRx's pe ratio was 37.3× on Nov 11, 2026, against 928.6× a year earlier. Over the last 2 years it ranged from 14.4× to 928.6×, with a median of 325.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 37.3× | −604.6 |
| 2022 | Jan 31, 2022 | 641.9× | −245.4 |
| 2021 | Dec 31, 2021 | 887.3× | +678.5 |
| 2020 | Feb 28, 2020 | 208.8× | −48.0 |
| 2019 | Dec 31, 2019 | 256.8× | −365.1 |
| 2016 | Jan 29, 2016 | 621.9× | −80.6 |
| 2015 | Dec 31, 2015 | 702.5× | – |
See a number that looks wrong?